NASDAQ: ADPT
Adaptive Biotechnologies Corp Stock Ownership - Who owns Adaptive Biotechnologies?

Insider buying vs selling

Have Adaptive Biotechnologies Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Julie RubinsteinCOO;Pres2026-11-1311,466$12.14
$139.20kBuy
Julie RubinsteinCOO;Pres2026-11-1311,466$28.93
$331.71kSell
Julie RubinsteinCOO;Pres2026-11-1211,881$12.14
$144.24kBuy
Julie RubinsteinCOO;Pres2026-11-1211,881$29.40
$349.30kSell
Julie RubinsteinCOO;Pres2026-11-116,898$31.22
$215.36kSell
Susan BobulskyCCO2026-11-111,875$32.00
$60.00kSell
Julie RubinsteinCOO;Pres2026-11-114,983$30.29
$150.94kSell
Julie RubinsteinCOO;Pres2026-11-1111,881$12.14
$144.24kBuy
Julie RubinsteinCOO;Pres2026-11-101,900$30.41
$57.78kSell
Julie RubinsteinCOO;Pres2026-11-109,981$29.35
$292.94kSell

1 of 34

ADPT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADPT insiders and whales buy or sell their stock.

ADPT Shareholders

What type of owners hold Adaptive Biotechnologies Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Viking Global Performance LLC19.15%30,993,708$900.06MInsider
Viking Global Investors LP18.53%29,993,708$871.02MInsider
David E. Goel7.60%12,310,594$357.50MInsider
Chad M. Robins3.41%5,518,018$160.24MInsider
Andris A. Zoltners2.24%3,621,016$105.15MInsider
Harlan S. Robins1.00%1,612,058$46.81MInsider
Tycho Peterson0.33%531,553$15.44MInsider
Susan Bobulsky0.24%387,475$11.25MInsider
Julie Rubinstein0.23%377,802$10.97MInsider
Kyle Piskel0.16%256,725$7.46MInsider

1 of 3

ADPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADPT0.05%53.77%Net SellingNet Selling
IONS0.08%3.35%Net SellingNet Buying
TVTX0.06%60.41%Net SellingNet Selling
COGT0.07%7.98%Net SellingNet Buying
DFTX0.05%34.72%Net SellingNet Selling

Adaptive Biotechnologies Stock Ownership FAQ

Who owns Adaptive Biotechnologies?

Adaptive Biotechnologies (NASDAQ: ADPT) is owned by 0.05% institutional shareholders, 53.77% Adaptive Biotechnologies insiders, and 46.17% retail investors. Viking Global Performance LLC is the largest individual Adaptive Biotechnologies shareholder, owning 30.99M shares representing 19.15% of the company. Viking Global Performance LLC's Adaptive Biotechnologies shares are currently valued at $900.06M.

If you're new to stock investing, here's how to buy Adaptive Biotechnologies stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.